Allison Roberts, PhD

Allison Roberts, PhD has a diverse work experience in various research roles. Allison started their career in 2012 as an intern at the California Institute of Technology, where they studied membrane protein expression. In 2013, they worked as an intern at the National Cancer Institute, focusing on assay development and peptide synthesis.

From 2014 to 2015, Allison worked as a Post baccalaureate CRTA at the National Cancer Institute, conducting research on developing imaging probes and characterizing tetrazole-based probes for detecting oncometabolites in specific cancers.

In the same year, they also worked as a Research Assistant at the MGH Center for Systems Biology, assisting in utilizing microfluidic technologies to map disease profiles through exosomal protein content. Their responsibilities included cell culture work, assay development, and antibody screening.

Since 2018, Allison has been working at Frontier Medicines, initially as a Scientist I-Chemical Biology, then progressing to Scientist II-Chemical Biology, and currently serving as a Senior Scientist. Their role at Frontier Medicines involves contributing to scientific research and development in the field of chemical biology.

Overall, Allison Roberts, PhD has shown a strong background in conducting research, assay development, and scientific analysis, with a focus on cancer-related studies and chemical biology.

Allison Roberts, PhD, holds a Doctor of Philosophy (Ph.D.) degree in Chemistry which was obtained from the University of California, Berkeley. Allison completed their doctoral studies from 2015 to 2018. Prior to their doctoral program, Allison earned a Bachelor of Science (BS) degree in Biochemistry from Syracuse University. Allison attended Syracuse University from 2010 to 2014.